The 51st ASCRS Annual Meeting Grandly Opens in Los Angeles – Xi’an Eyedeal Impresses with Its Presence
On April 25, the 51st Annual Meeting of the American Society of Cataract and Refractive Surgery (ASCRS 2025) officially opened in Los Angeles, USA. Xi’an Eyedeal Medical Technology Co., Ltd. drew widespread industry attention with its innovative biomedical materials and next-generation cross-linked polyolefin (xPIB) intraocular lens showcased at the event.
Live from the Scene – Highlight 1:
Innovative Biomedical Materials Platform Unlocks Global Collaboration Opportunities
On the opening day of the conference, the core exhibition hall of the Los Angeles Convention Center was already bustling with attendees of all backgrounds. As a global trendsetter in the ophthalmology field, ASCRS attracts ophthalmic experts and representatives from pharmaceutical and medical device companies worldwide, all eager to discover the latest technologies and innovations poised to drive industry transformation.
At Booth #701, the Xi’an Eyedeal team—including Chairman and CEO Mr. Guangxu Guo, Chief Technology Officer Mr. Zhou Yang, Vice President of R&D Ms. Yin Yang, and Chief Medical Officer Dr. Qun Peng—presented the company’s biomedical materials platform. They introduced its technical features, performance indicators, development potential, and models for commercial collaboration.
Developed entirely in-house by Xi’an Eyedeal, the xPIB platform is based on a high-performance isobutylene-based copolymer, cross-linked polyolefin. This material supports a wide range of ophthalmic applications, from anterior chamber to posterior chamber devices, addressing clinical needs in cataract, glaucoma, and refractive treatments. Upon learning that Eyedeal has already established successful partnerships beyond IOLs—with U.S. corneal bioengineering firms, Australian research institutions, and top-tier Chinese clinical centers—many visitors expressed strong interest in collaboration.
Dr. Francesco Negroni, an ophthalmologist from Germany, remarked:
“I’ve been closely following polyisobutylene-based materials. Their stability and biocompatibility are impressive. The cross-linked polyolefin (xPIB) platform developed from this foundation shows vast and diverse application potential—it’s truly exciting. I look forward to seeing this innovative material more broadly used in clinical practice.”
Additionally, potential collaborators from India, Pakistan, and emerging Latin American markets also expressed keen interest, creating a lively and enthusiastic atmosphere at the booth.
Live from the Scene – Highlight 2:
Cross-Linked Polyolefin IOL May Revolutionize Global Ophthalmic Technology
Just like the materials platform, Eyedeal’s independently developed next-generation xPIB intraocular lens received high praise and attention from ophthalmic professionals worldwide. Many doctors closely examined the lens samples, touching and stretching them to experience firsthand their excellent optical clarity and mechanical properties—eliciting enthusiastic reactions.
Dr. Manel Morros, an ophthalmologist from Spain, commented:”Achieving a 6.5mm to 8mm ultra-large optic design with micro-incision implantation using cross-linked polyolefin is an impressive feat. If this lens also addresses common industry issues such as glare, halos, and calcification, then it could represent a groundbreaking innovation that revolutionizes the global IOL industry.”
The four-day ASCRS 2025 Annual Meeting remains one of the most influential academic events in the global ophthalmology community. The conference is dedicated to sharing the latest advancements, research findings, and clinical experiences in cataract and refractive surgery. Through panel discussions, lectures, and live surgical demonstrations, ASCRS promotes academic exchange and progress in ophthalmic medicine worldwide.